These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26269798)

  • 1. Conditionally replicating adenovirus prevents pluripotent stem cell-derived teratoma by specifically eliminating undifferentiated cells.
    Mitsui K; Ide K; Takayama A; Wada T; Irie R; Kosai K
    Mol Ther Methods Clin Dev; 2015; 2():15026. PubMed ID: 26269798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survivin-responsive conditionally replicating adenovirus exhibits cancer-specific and efficient viral replication.
    Kamizono J; Nagano S; Murofushi Y; Komiya S; Fujiwara H; Matsuishi T; Kosai K
    Cancer Res; 2005 Jun; 65(12):5284-91. PubMed ID: 15958575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of an altered E1B promoter on the specificity and potency of triple-regulated conditionally replicating adenoviruses: implications for the generation of ideal m-CRAs.
    Horikawa Y; Wang Y; Nagano S; Kamizono J; Ikeda M; Komiya S; Kosai KI
    Cancer Gene Ther; 2011 Oct; 18(10):724-33. PubMed ID: 21836631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy.
    Watanabe M; Nishikawaji Y; Kawakami H; Kosai KI
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survivin-responsive conditionally replicating adenovirus kills rhabdomyosarcoma stem cells more efficiently than their progeny.
    Tanoue K; Wang Y; Ikeda M; Mitsui K; Irie R; Setoguchi T; Komiya S; Natsugoe S; Kosai K
    J Transl Med; 2014 Jan; 12():27. PubMed ID: 24467821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survivin-responsive, conditionally replicating adenovirus induces potent cytocidal effects in adult T-cell leukemia/lymphoma.
    Suzuki S; Kofune H; Uozumi K; Yoshimitsu M; Arima N; Ishitsuka K; Ueno SI; Kosai KI
    BMC Cancer; 2019 May; 19(1):516. PubMed ID: 31142289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral Vector-Based Innovative Approaches to Directly Abolishing Tumorigenic Pluripotent Stem Cells for Safer Regenerative Medicine.
    Mitsui K; Ide K; Takahashi T; Kosai KI
    Mol Ther Methods Clin Dev; 2017 Jun; 5():51-58. PubMed ID: 28480304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Construction of Lentiviral Vectors for Eliminating Tumorigenic Cells from Pluripotent Stem Cells.
    Ide K; Mitsui K; Irie R; Matsushita Y; Ijichi N; Toyodome S; Kosai KI
    Stem Cells; 2018 Feb; 36(2):230-239. PubMed ID: 29067732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of pluripotent stem cell-derived teratoma formation by small molecules.
    Lee MO; Moon SH; Jeong HC; Yi JY; Lee TH; Shim SH; Rhee YH; Lee SH; Oh SJ; Lee MY; Han MJ; Cho YS; Chung HM; Kim KS; Cha HJ
    Proc Natl Acad Sci U S A; 2013 Aug; 110(35):E3281-90. PubMed ID: 23918355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An efficient construction of conditionally replicating adenoviruses that target tumor cells with multiple factors.
    Nagano S; Oshika H; Fujiwara H; Komiya S; Kosai K
    Gene Ther; 2005 Sep; 12(18):1385-93. PubMed ID: 15877049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of selective cytotoxic viral vectors for concentration of undifferentiated cells in cardiomyocytes derived from human induced pluripotent stem cells.
    Kono K; Sawada R; Kuroda T; Yasuda S; Matsuyama S; Matsuyama A; Mizuguchi H; Sato Y
    Sci Rep; 2019 Mar; 9(1):3630. PubMed ID: 30842516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective elimination of human pluripotent stem cells by Anti-Dsg2 antibody-doxorubicin conjugates.
    Park J; Lee NG; Oh M; Song J; Kim W; Kwon MG; Kim SG; Han BS; Bae KH; Lee DG; Lee SH; Park JG; Kim JH; Lee J; Min JK
    Biomaterials; 2020 Nov; 259():120265. PubMed ID: 32827795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation-Defective Human Induced Pluripotent Stem Cells Reveal Strengths and Limitations of the Teratoma Assay and In Vitro Pluripotency Assays.
    Bouma MJ; van Iterson M; Janssen B; Mummery CL; Salvatori DCF; Freund C
    Stem Cell Reports; 2017 May; 8(5):1340-1353. PubMed ID: 28494940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety of human pluripotent stem cells in clinical treatment.
    Simonson OE; Domogatskaya A; Volchkov P; Rodin S
    Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteolin Induces Selective Cell Death of Human Pluripotent Stem Cells.
    Go YH; Kim J; Jeong HC; Kim SM; Kim YJ; Park SJ; Moon SH; Cha HJ
    Biomedicines; 2020 Oct; 8(11):. PubMed ID: 33121085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma-activated medium selectively eliminates undifferentiated human induced pluripotent stem cells.
    Matsumoto R; Shimizu K; Nagashima T; Tanaka H; Mizuno M; Kikkawa F; Hori M; Honda H
    Regen Ther; 2016 Dec; 5():55-63. PubMed ID: 31245502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of Differentiation Tendency Toward Hepatocytes from Gene Expression in Undifferentiated Human Pluripotent Stem Cells.
    Yanagihara K; Liu Y; Kanie K; Takayama K; Kokunugi M; Hirata M; Fukuda T; Suga M; Nikawa H; Mizuguchi H; Kato R; Furue MK
    Stem Cells Dev; 2016 Dec; 25(24):1884-1897. PubMed ID: 27733097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumorigenicity studies for human pluripotent stem cell-derived products.
    Kuroda T; Yasuda S; Sato Y
    Biol Pharm Bull; 2013; 36(2):189-92. PubMed ID: 23370350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethanol extract of Magnoliae cortex (EEMC) limits teratoma formation of pluripotent stem cells by selective elimination of undifferentiated cells through the p53-dependent mitochondrial apoptotic pathway.
    Kim A; Lee SY; Seo CS; Chung SK
    Phytomedicine; 2020 Apr; 69():153198. PubMed ID: 32151917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.
    Hemmi N; Tohyama S; Nakajima K; Kanazawa H; Suzuki T; Hattori F; Seki T; Kishino Y; Hirano A; Okada M; Tabei R; Ohno R; Fujita C; Haruna T; Yuasa S; Sano M; Fujita J; Fukuda K
    Stem Cells Transl Med; 2014 Dec; 3(12):1473-83. PubMed ID: 25355733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.